Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07280247 · ClinicalTrials.gov registry record · NA
Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness
A NA study, sponsored by Angiodynamics.
- Recruiting
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT07280247 is a NA study that is actively recruiting participants, run by Angiodynamics. The registered enrollment target is 39 participants.
The verdict
NCT07280247, a NA study, is actively recruiting participants, sponsored by Angiodynamics.
- RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.
Interventions
- DEVICE AlphaReturn Blood Management System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07280247
The ClinicalTrials.gov registry entry for NCT07280247 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angiodynamics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AlphaReturn Blood Management System is the first listed.
NCT07280247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07280247 about?
NCT07280247 is a clinical study titled "Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness". The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.
What is the current status of trial NCT07280247?
This trial is currently recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2026-03-30. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07280247?
The interventions under investigation include: AlphaReturn Blood Management System (DEVICE).
Who is sponsoring clinical trial NCT07280247?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.